Sugi Predict

Sugi Predict / Compounds / SCHEMBL29982290

SCHEMBL29982290

SCHEMBL29982290

CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C(C)C)N(C)F)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)CC

nearest known ligand 0.54

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ KISS1R Q969F8 18/20 0.54
▸ IL23R Q5VWK5 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29982442 1.00 KISS1R (0.54) KISS1RIL23R
SCHEMBL29982283 0.90 KISS1R (0.62) KISS1RIL23R
SCHEMBL30401709 0.90 KISS1R (0.62) KISS1RIL23R
SCHEMBL30401759 0.88 KISS1R (0.61) KISS1RIL23R
SCHEMBL29981946 0.88 KISS1R (0.59) KISS1RIL23R
SCHEMBL29981974 0.88 KISS1R (0.59) KISS1RIL23R
SCHEMBL30093011 0.87 IL23R (0.54) KISS1RIL23R
SCHEMBL30956236 0.86 GHSR (0.63) KISS1R
SCHEMBL29415985 0.84 KISS1R (0.64) KISS1R
SCHEMBL1373223 0.84 KISS1R (0.61) KISS1RIL23R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240390508-A1 HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE-DRUG CONJUGATE TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2024-11-28 — — US claimed
EP-4389893-A1 HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE-DRUG CONJUGATE Takeda Pharmaceutical Company Limited (JP) 2024-06-26 — — EP claimed
US-20230203098-A1 HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE JCR PHARMACEUTICALS CO., LTD. (JP) 2023-06-29 — — US claimed
WO-2023026994-A1 HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE-DRUG CONJUGATE 武田薬品工業株式会社 2023-03-02 — — WO claimed
EP-4108676-A1 HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE JCR Pharmaceuticals Co., Ltd. (JP) 2022-12-28 — — EP claimed
CN-115151556-A Human transferrin receptor binding peptides JCR制药股份有限公司 2022-10-04 — — CN claimed
US-20240390508-A1 HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE-DRUG CONJUGATE TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2024-11-28 — — US disclosed
EP-4389893-A1 HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE-DRUG CONJUGATE Takeda Pharmaceutical Company Limited (JP) 2024-06-26 — — EP disclosed
US-20230203098-A1 HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE JCR PHARMACEUTICALS CO., LTD. (JP) 2023-06-29 — — US disclosed
WO-2023026994-A1 HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE-DRUG CONJUGATE 武田薬品工業株式会社 2023-03-02 — — WO disclosed
EP-4108676-A1 HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE JCR Pharmaceuticals Co., Ltd. (JP) 2022-12-28 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240390508-A1 HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE-DRUG CONJUGATE MUSK, TFRC, SLC7A1 KISS1R 2887/4885IL23R 2841/4885
US-20230203098-A1 HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE TFRC, SLC3A2, SLC7A1 KISS1R 1171/4885IL23R 1413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback